291 related articles for article (PubMed ID: 30035130)
1. Inflammation in the Tumor Microenvironment.
Lin Q; Jin S; Han M; Zheng W; Liu J; Wei X
J Immunol Res; 2018; 2018():1965847. PubMed ID: 30035130
[No Abstract] [Full Text] [Related]
2. STING signaling: a key to therapeutic tumor immunity.
Foote JB; Emens LA
Immunotherapy; 2018 Jul; 10(9):729-731. PubMed ID: 30008260
[No Abstract] [Full Text] [Related]
3. Cancer vaccines in the era of checkpoint blockade: the magic is in the adjuvant.
Overwijk WW
Curr Opin Immunol; 2017 Aug; 47():103-109. PubMed ID: 28806603
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
Sasidharan Nair V; Elkord E
Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
6. The Dual Role of Treg in Cancer.
Frydrychowicz M; Boruczkowski M; Kolecka-Bednarczyk A; Dworacki G
Scand J Immunol; 2017 Dec; 86(6):436-443. PubMed ID: 28941312
[TBL] [Abstract][Full Text] [Related]
7. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
[No Abstract] [Full Text] [Related]
8. Addressing tumour tolerance to improve cancer immunotherapy.
Meyer RG; Herr W
Eur J Immunol; 2010 Dec; 40(12):3302-5. PubMed ID: 21110313
[No Abstract] [Full Text] [Related]
9. Potential targeting of B7-H4 for the treatment of cancer.
Podojil JR; Miller SD
Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701
[TBL] [Abstract][Full Text] [Related]
10. T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.
Ma W; Chen X; Yuan Y
Immunotherapy; 2017 Jun; 9(7):523-525. PubMed ID: 28595519
[No Abstract] [Full Text] [Related]
11. Recent progress in GM-CSF-based cancer immunotherapy.
Yan WL; Shen KY; Tien CY; Chen YA; Liu SJ
Immunotherapy; 2017 Mar; 9(4):347-360. PubMed ID: 28303764
[TBL] [Abstract][Full Text] [Related]
12. Coinhibitory Pathways in Immunotherapy for Cancer.
Baumeister SH; Freeman GJ; Dranoff G; Sharpe AH
Annu Rev Immunol; 2016 May; 34():539-73. PubMed ID: 26927206
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells, as a target in anticancer immunotherapy.
Enokida T; Nishikawa H
Immunotherapy; 2017 Jun; 9(8):623-627. PubMed ID: 28653572
[No Abstract] [Full Text] [Related]
14. Role of heterogeneous regulatory T cells in the tumor microenvironment.
Wei T; Zhong W; Li Q
Pharmacol Res; 2020 Mar; 153():104659. PubMed ID: 31982490
[TBL] [Abstract][Full Text] [Related]
15. [Regulatory T cells in cancer immunotherapy].
Nishikawa H
Rinsho Ketsueki; 2014 Oct; 55(10):2183-9. PubMed ID: 25297785
[No Abstract] [Full Text] [Related]
16. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
17. "Tumor immunology meets oncology (TIMO) VI" from 7th to 8th of May 2010 in Halle, Germany.
Quandt D; Massa C; Seliger B
Cancer Immunol Immunother; 2011 Feb; 60(2):299-303. PubMed ID: 20803010
[No Abstract] [Full Text] [Related]
18. Innate immune mediators in cancer: between defense and resistance.
Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
[TBL] [Abstract][Full Text] [Related]
19. Production of monoclonal antibodies in plants for cancer immunotherapy.
Moussavou G; Ko K; Lee JH; Choo YK
Biomed Res Int; 2015; 2015():306164. PubMed ID: 26550566
[TBL] [Abstract][Full Text] [Related]
20. Roles of regulatory T cells in cancer immunity.
Takeuchi Y; Nishikawa H
Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
